Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents

被引:3
|
作者
Tanaka, Reiko [1 ]
Tsujii, Hiroko [1 ]
Yamada, Takeshi [1 ]
Kajimoto, Tetsuya [1 ]
Tokuda, Harukuni [2 ]
Arai, Takanari [2 ]
Suzuki, Nobutaka [2 ]
Hasegawa, Junya [3 ]
Hamashima, Yoshio [3 ]
Node, Manabu [3 ]
机构
[1] Osaka Univ Pharmaceut Sci, Med Chem Lab, Osaka 5691094, Japan
[2] Kanazawa Univ, R&D Grad Sch Med Sci, Dept Complementary & Alternat Med, Kanazawa, Ishikawa 9208640, Japan
[3] Kyoto Pharmaceut Univ, Dept Pharmaceut Mfg Chem, Yamashina Ku, Kyoto 6078414, Japan
关键词
3 alpha-methoxyserrat-14-en-21 beta-ol (PJ-1); 3 beta-methoxyserrat-14-en-21 beta-ol (PJ-2); 3,3-dimethyl-succinyl derivatives; Epstein-Barr virus early antigen (EBV-EA) activation; In vivo two-stage mouse-skin carcinogenesis test; SERRATANE-TYPE TRITERPENOIDS; ANTITUMOR AGENTS; ACID; FLAVONOIDS; HYBRIDS;
D O I
10.1016/j.ejmech.2011.04.062
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
3 alpha-Methoxyserrat-14-en-21 beta-ol (PJ-1) and 3 beta-methoxyserrat-14-en-21 beta-ol (PJ-2) were conjugated with well-known phenolic compounds, narigenin, hesperetin, genistein, and daidzein (1-8). Other conjugates of PJ-2-3,5-dihydroxy-4-methoxybenzoic acid (9), PJ-2 pyrogallol (10), and derivatives of PJ-1, PJ-2-3,3-dimethyl-succinates (11, 12), PJ-1, PJ-2 succinates (13, 14), PJ-2 glycine (15), PJ-2 piperidine acetic acid (16), and PJ-1 epoxy-3,3-dimethyl-succinate (17) were tested for their inhibitory effects on Epstein Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). The inhibitory effects of 11 (IC50 = 251),12 (IC50 = 248), and 17 (IC50= 230 mol ratio/32 pmol/TPA), were 2-fold stronger than those of the other compounds such as oleanolic acid (IC50 = 449). Compounds 10, 11, and 17 inhibited mouse skin tumor promotion in an in vivo two-stage carcinogenesis model. The in vivo two-stage mouse-skin carcinogenesis test employed 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3368 / 3375
页数:8
相关论文
共 31 条
  • [31] Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer
    William, Anthony D.
    Lee, Angeline C. -H.
    Goh, Kee Chuan
    Blanchard, Stephanie
    Poulsen, Anders
    Teo, Ee Ling
    Nagaraj, Harish
    Lee, Chai Ping
    Wang, Haishan
    Williams, Meredith
    Sun, Eric T.
    Hu, Changyong
    Jayaraman, Ramesh
    Pasha, Mohammed Khalid
    Ethirajulu, Kantharaj
    Wood, Jeanette M.
    Dymock, Brian W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 169 - 196